BioNote Stock

BioNote Gross Profit

The Gross Profit of BioNote (377740.KS) as of Aug 17, 2026 is 51.24 B KRW. In the previous year, Gross Profit was -11.57 B KRW — a change of -542.90% (higher).

Gross Profit

51.24 BKRW

YoY

-542.90%

Last updated:

Gross Profit of BioNote is 2026 51.24 B KRW. Gross Profit of BioNote was 2025 -11.57 B KRW. It decreases by -542.90% higher compared to the previous year.

The BioNote Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2019
46.75 base
Jan 1, 2020
91.78 base
Jan 1, 2021
82.28 base
Jan 1, 2022
71.04 base
Jan 1, 2023
-12.84 base
Jan 1, 2024
49.85 base
Jan 1, 2025 (e)
33.72 base
Jan 1, 2026 (e)
26.06 base
YEARGROSS MARGIN (%)
2026 est 26.06
2025 est 33.72
2024 49.85
2023 -12.84
2022 71.04
2021 82.28
2020 91.78
2019 46.75
Access this data via the Eulerpool API
Get Free API Key

BioNote Revenue

BioNote Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
40.05 B KRW
9.93 B KRW
20.61 B KRW
Jan 1, 2020
631.50 B KRW
558.03 B KRW
528.23 B KRW
Jan 1, 2021
622.36 B KRW
468.75 B KRW
676.60 B KRW
Jan 1, 2022
479.66 B KRW
295.41 B KRW
307.80 B KRW
Jan 1, 2023
90.08 B KRW
-47.04 B KRW
-20.50 B KRW
Jan 1, 2024
102.78 B KRW
12.22 B KRW
55.26 B KRW
Jan 1, 2025 (e)
151.97 B KRW
13.30 B KRW
17.30 B KRW
Jan 1, 2026 (e)
196.62 B KRW
23.67 B KRW
31.74 B KRW

BioNote Margins

BioNote stock margins

The BioNote margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioNote. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioNote.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
46.75 %
24.79 %
51.47 %
Jan 1, 2020
91.78 %
88.37 %
83.65 %
Jan 1, 2021
82.28 %
75.32 %
108.72 %
Jan 1, 2022
71.04 %
61.59 %
64.17 %
Jan 1, 2023
-12.84 %
-52.22 %
-22.75 %
Jan 1, 2024
49.85 %
11.88 %
53.77 %
Jan 1, 2025 (e)
49.85 %
8.75 %
11.38 %
Jan 1, 2026 (e)
49.85 %
12.04 %
16.14 %

BioNote Stock analysis

What does BioNote do? BioNote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNote stock

Gross Profit of BioNote is 51.24 B KRW in 2026.

Gross Profit of BioNote changed from -11.57 B KRW to 51.24 B KRW, representing a -542.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit BioNote since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's BioNote historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioNote

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioNote